Argenica Therapeutics prepares for phase one trial of neuroprotective drug

420:50:00
ASX:AGN

Watch the video above for detailed insights and analysis.

Video Details

Featured Companies: ASX:AGN
Recorded:

Stay Ahead

Get the latest market insights and analysis delivered to your inbox.